Aquestive Therapeutics, Inc. (AQST)
4.32
+0.09
(+2.13%)
USD |
NASDAQ |
May 08, 16:00
4.315
0.00 (0.00%)
After-Hours: 20:00
Aquestive Therapeutics EPS Diluted (Quarterly) : -0.2612 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nektar Therapeutics | -1.815 |
| Crinetics Pharmaceuticals, Inc. | -1.228 |
| Harrow, Inc. | 0.178 |
| Journey Medical Corp. | -0.0459 |
| Corcept Therapeutics, Inc. | -0.2988 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -31.86M |
| Revenue (Quarterly) | 13.02M |
| Total Expenses (Quarterly) | 44.88M |
| Enterprise Value | 537.51M |
| Gross Profit Margin (Quarterly) | 55.16% |
| Profit Margin (Quarterly) | -244.8% |
| Earnings Yield | -18.00% |
| Normalized Earnings Yield | -18.00 |